Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human mid tetramer

被引:182
作者
Kita, H
Naidenko, OV
Kronenberg, M
Ansari, AA
Rogers, P
He, XS
Koning, F
Mikayama, T
Van de Water, J
Coppel, RL
Kaplan, M
Gershwin, ME
机构
[1] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA
[2] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA USA
[3] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
[4] Leiden Univ, Dept Immunohaematol, Leiden, Netherlands
[5] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia
[6] Tufts Univ, Gastroenterol Serv, Boston, MA USA
关键词
D O I
10.1053/gast.2002.36020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Natural killer T (NKT) cells are a subset of lymphocytes incriminated in playing an important role in the modulation of the innate immune response and the development of autoimmunity. However, there have been only limited studies attempting to quantitate the number of NKT cells in autoimmune disease, particularly because of difficulties associated with definition of this subpopulation. Methods: We used a human CD1d (hCD1d) tetramer produced by a baculovirus expressing recombinant CD1d protein complexed with alpha-galactosylceramide (alpha-GalCer) and quantitated hCD1d tetramer reactive cells in blood and liver from controls and patients with primary biliary cirrhosis (PBC). Results: The majority of CD1d-alphaGalCer-restricted NKT cells were positive for TCR Valpha24 and Vbeta11. There was a distinct CD4(-) CD8(+) population within the CD1d-alphaGalCer-restricted NKT cells in addition to the CD4(-) CD8(-) and CD4(+) CD8- population. The frequency of CD1d-alphaGalCer-restricted NKT cells was similar between blood and liver in healthy individuals. In contrast, the frequency of CD1d-alphaGalCer-restricted NKT cells in the liver was significantly higher than in the blood of PBC patients. The frequency of CD1d-alpha-GalCer-restricted NKT cells in the liver was also significantly higher in PBC patients than in healthy individuals. Conclusions: The frequency and function of such cells should be studied not only in blood but also in the target organ of the autoimmune disease. Selective enrichment of CD1d-alphaGalCer-restricted NKT cells at the site of inflammation is observed in PBC, suggesting a role of these cells in the development of PBC.
引用
收藏
页码:1031 / 1043
页数:13
相关论文
共 51 条
[11]   Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice:: A major role for bone marrow in NKT cell homeostasis [J].
Eberl, G ;
MacDonald, HR .
IMMUNITY, 1998, 9 (03) :345-353
[12]   Requirements for CD1d recognition by human invariant V alpha 24(+) CD4(-)CD8(-) T cells [J].
Exley, M ;
Garcia, J ;
Balk, SP ;
Porcelli, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :109-120
[13]   CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptorα chains [J].
Exley, M ;
Porcelli, S ;
Furman, M ;
Garcia, J ;
Balk, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :867-876
[14]   Flow cytometric study of T cell development in NOD mice reveals a deficiency in alpha beta TCR(+)CD4(-)CD8(-) thymocytes [J].
Godfrey, DI ;
Kinder, SJ ;
Silvera, P ;
Baxter, AG .
JOURNAL OF AUTOIMMUNITY, 1997, 10 (03) :279-285
[15]   NKT cells: facts, functions and fallacies [J].
Godfrey, DI ;
Hammond, KJL ;
Poulton, LD ;
Smyth, MJ ;
Baxter, AG .
IMMUNOLOGY TODAY, 2000, 21 (11) :573-583
[16]   Early quantitative and functional deficiency of NK1(+)-like thymocytes in the NOD mouse [J].
Gombert, JM ;
Herbelin, A ;
TancredeBohin, E ;
Dy, M ;
Carnaud, C ;
Bach, JF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) :2989-2998
[17]   α/β-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10 [J].
Hammond, KJL ;
Poulton, LD ;
Palmisano, LJ ;
Silveira, PA ;
Godfrey, DI ;
Baxter, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :1047-1056
[18]   The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice [J].
Hong, S ;
Wilson, MT ;
Serizawa, I ;
Wu, L ;
Singh, N ;
Naidenko, OV ;
Miura, T ;
Haba, T ;
Scherer, DC ;
Wei, J ;
Kronenberg, M ;
Koezuka, Y ;
Van Kaer, L .
NATURE MEDICINE, 2001, 7 (09) :1052-1056
[19]   Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy [J].
Illés, Z ;
Kondo, T ;
Newcombe, J ;
Oka, N ;
Tabira, T ;
Yamamura, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4375-4381
[20]   α-Glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro [J].
Ishihara, S ;
Nieda, M ;
Kitayama, J ;
Osada, T ;
Yabe, T ;
Kikuchi, A ;
Koezuka, Y ;
Porcelli, SA ;
Tadokoro, K ;
Nagawa, H ;
Juji, T .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1659-1664